Trials / Completed
CompletedNCT00935662
A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses
A Randomised, Single-blind, Placebo-controlled, Two-centre Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of AZD8329 After Single Ascending Oral Doses
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 119 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary objective for this study is to assess the safety and tolerability of AZD8329 when given as a single dose in increasing dose strength, and also to identify the highest tolerated dose for future studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD8329 | Oral solution, single ascending doses |
| DRUG | Placebo | Oral solution, placebo |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-07-09
- Last updated
- 2010-09-13
Locations
2 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00935662. Inclusion in this directory is not an endorsement.